Earnings Call Transcript - Q1FY21 for Biocon

Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer

338.2000 8.35 (2.53%)

NSE May 14, 2025 15:31 PM

25.47% Gain from 52W Low

Volume: 3.2M

Conference/Earnings Calls Alerts

Biocon Ltd.

24 Jul 2020

338.20

2.53%

Earnings Call Transcript - Q1FY21 for Biocon

Conference Call with Biocon Management and Analysts on Q1FY21 Performance and Outlook. Listen to the full earnings transcript.

More from Biocon Ltd.

Recommended

Market closes higher, HAL's Q4 revenue beats Forecaster estimates by 13.5%

Trendlyne Marketwatch | 14 May 2025, 03:55PM

Chart of the week: From partnerships to diversification: Dixon Technologies powers ahead to new highs

The Baseline | 14 May 2025, 09:48AM

A long drawn out R&D plan may be finally paying off for Biocon